View ValuationDigicann Ventures 将来の成長Future 基準チェック /06現在、 Digicann Venturesの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Pharmaceuticals 収益成長21.8%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Dec 02Digicann Ventures Inc. Appoints Jordan Fogle as A Director, Effective December 2, 2025Digicann Ventures Inc. announced the appointment of Jordan Fogle as a director of the Company. Jordan's appointment as a member of the board of directors (the "Board") is effective on December 2, 2025 and is subject to all applicable regulatory approvals.お知らせ • Oct 303WIN Corp. cancelled the acquisition of Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction.3WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction for CAD 39.7 million on August 1, 2024. On September 27, 2024, Digicann Ventures entered into a Definitive Agreement for Proposed RTO Transaction with 3Win Corp. Pursuant to the terms of the LOI, the holders of Digicann Shares shall receive a deemed value of CAD 0.05 per share and, upon completion of the Proposed Transaction, 3Win Corp. expects to affect a name change to “Serewin Inc.”. A sub-committee of Digicann’s board of directors (excluding Mr. Kuzyk) determined that the Agreement, including the transactions and other steps contemplated thereunder, is fair to holders of Digicann securities and is in the best interests of the Company. As of January 13, 2025 3Win has elected to postpone the Proposed Transaction to the second quarter of 2025 in order to include its 2024 audited financial results in the disclosures required for listing on the Canadian Securities Exchange. Accordingly, Digicann’s board of directors approved the Agreement and recommends that holders vote their shares in favour of the Proposed Transaction. Completion of the Proposed Transaction is subject to a number of conditions precedent, including but not limited to, the parties entering into a Definitive Agreement, Digicann having a minimum amount of cash at closing of the Proposed Transaction, as well as receipt of all required shareholder, regulatory, and other approvals. Pursuant to the terms of the Definitive Agreement, 3Win shall acquire all the shares of the Company, in the exchange ratio of ninety-eight shares of the Company per one share of 3Win. Upon completion of the Proposed Transaction, the resulting holders of all issued and outstanding shares of 3Win (“3Win Shares”) shall hold approximately 97.3% of the issued and outstanding common shares of the Resulting Issuer (the “Exchange Ratio”), subject to adjustment in certain circumstances and for any additional amounts invested by third parties into 3Win to satisfy any liquidity conditions imposed by the Exchange in connection with the Proposed Transaction. It is also anticipated that all securities convertible, exercisable or exchangeable for 3Win Shares will be converted or exchange (or otherwise become convertible or exercisable in accordance with their terms) into similar securities of the Resulting Issuer on substantially similar terms and conditions based on the Exchange Ratio. All outstanding stock options and common share purchase warrants of the Company are anticipated to remain in effect on substantially the same terms. 3WIN Corp. cancelled the acquisition of Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction on October 29, 2025.お知らせ • Mar 12Digicann Ventures Inc. announced a financing transactionDigicann Ventures Inc. announced that it has entered into an agreement with the holders of the company to issue 10% Senior Unsecured Convertible Debentures to receive funding on March 12, 2025. The maturity date of the debentures is March 12, 2026.お知らせ • Aug 043WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) for CAD 0.22 million.3WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) for CAD 0.22 million on August 1, 2024. Pursuant to the terms of the LOI, the holders of Digicann Shares shall receive a deemed value of CAD 0.05 per share and, upon completion of the Proposed Transaction3Win Corp. expects to affect a name change to “Serewin Inc.”. Completion of the Proposed Transaction is subject to a number of conditions precedent, including but not limited to, the parties entering into a Definitive Agreement, Digicann having a minimum amount of cash at closing of the Proposed Transaction, as well as receipt of all required shareholder, regulatory, and other approvals.New Risk • May 02New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (91% average weekly change). Negative equity (-CA$620k). Shareholders have been substantially diluted in the past year (298% increase in shares outstanding). Revenue is less than US$1m. Market cap is less than US$10m (€295.1k market cap, or US$315.8k). Minor Risk Large one-off items impacting financial results.Reported Earnings • Nov 19Third quarter 2023 earnings released: EPS: CA$0.11 (vs CA$0.87 loss in 3Q 2022)Third quarter 2023 results: EPS: CA$0.11 (up from CA$0.87 loss in 3Q 2022). Revenue: CA$113.7k (down 34% from 3Q 2022). Net income: CA$880.0k (up CA$3.25m from 3Q 2022).お知らせ • Oct 24An unknown buyer acquired Agraflora Europe Gmbh from Digicann Ventures Inc. (CNSX:DCNN) for €0.5 million recently.An unknown buyer acquired Agraflora Europe Gmbh from Digicann Ventures Inc. (CNSX:DCNN) for €0.5 million recently on October 23, 2023. This transaction is governed exclusively by the laws of Germany subject to the exclusion of German conflicts of laws rules (IPR).Reported Earnings • Sep 03Second quarter 2023 earnings released: EPS: CA$0.60 (vs CA$4.16 loss in 2Q 2022)Second quarter 2023 results: EPS: CA$0.60 (up from CA$4.16 loss in 2Q 2022). Revenue: CA$142.8k (up 4.1% from 2Q 2022). Net income: CA$3.64m (up CA$7.75m from 2Q 2022). このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Digicann Ventures は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測MUN:VY3 - アナリストの将来予測と過去の財務データ ( )CAD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数9/30/2024N/A13-2-2N/A6/30/2024N/A13-2-2N/A3/31/2024N/A15-3-3N/A12/31/2023N/A15-3-3N/A9/30/20230-18-1-1N/A6/30/20230-19-1-1N/A3/31/20230-23-1-1N/A12/31/20220-20-1-1N/A9/30/20221033N/A6/30/20221122N/A3/31/20221-1-7-7N/A12/31/20211-1-6-6N/A9/30/20211-83-10-11N/A6/30/20211-88-10-10N/A3/31/20211-91-30N/A12/31/20201-103-10-5N/A9/30/20201-660-10N/A6/30/20201-98-20-11N/A3/31/20200-104-24-17N/A12/31/20190-101-18-14N/A9/30/2019N/A-57-30-8N/A6/30/2019N/A-21-10-9N/A3/31/2019N/A-10-4-4N/A12/31/2018N/A-6-3-3N/A9/30/2018N/A-6-4-4N/A6/30/2018N/A-5N/A-2N/A3/31/2018N/A-4N/A-2N/A12/31/2017N/A-2N/A-2N/A9/30/2017N/A-2N/A-2N/A6/30/20170-3N/A-1N/A3/31/2017N/A-2N/A-1N/A12/31/20160-2N/A0N/A9/30/20160-1N/A0N/A6/30/20160-1N/A-1N/A3/31/20160-1N/A-1N/A12/31/20150-1N/A-1N/A9/30/20150-1N/A-1N/A6/30/20150-1N/A-1N/A3/31/2015N/A-1N/A-1N/A12/31/2014N/A-1N/A-1N/A9/30/2014N/A-3N/A-1N/A6/30/2014N/A-3N/A0N/A3/31/2014N/A-2N/A0N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: VY3の予測収益成長が 貯蓄率 ( 1% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: VY3の収益がGerman市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: VY3の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: VY3の収益がGerman市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: VY3の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: VY3の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2024/12/28 21:19終値2024/09/30 00:00収益2024/09/30年間収益2023/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Digicann Ventures Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Siddharth RajeevFundamental Research Corp.
お知らせ • Dec 02Digicann Ventures Inc. Appoints Jordan Fogle as A Director, Effective December 2, 2025Digicann Ventures Inc. announced the appointment of Jordan Fogle as a director of the Company. Jordan's appointment as a member of the board of directors (the "Board") is effective on December 2, 2025 and is subject to all applicable regulatory approvals.
お知らせ • Oct 303WIN Corp. cancelled the acquisition of Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction.3WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction for CAD 39.7 million on August 1, 2024. On September 27, 2024, Digicann Ventures entered into a Definitive Agreement for Proposed RTO Transaction with 3Win Corp. Pursuant to the terms of the LOI, the holders of Digicann Shares shall receive a deemed value of CAD 0.05 per share and, upon completion of the Proposed Transaction, 3Win Corp. expects to affect a name change to “Serewin Inc.”. A sub-committee of Digicann’s board of directors (excluding Mr. Kuzyk) determined that the Agreement, including the transactions and other steps contemplated thereunder, is fair to holders of Digicann securities and is in the best interests of the Company. As of January 13, 2025 3Win has elected to postpone the Proposed Transaction to the second quarter of 2025 in order to include its 2024 audited financial results in the disclosures required for listing on the Canadian Securities Exchange. Accordingly, Digicann’s board of directors approved the Agreement and recommends that holders vote their shares in favour of the Proposed Transaction. Completion of the Proposed Transaction is subject to a number of conditions precedent, including but not limited to, the parties entering into a Definitive Agreement, Digicann having a minimum amount of cash at closing of the Proposed Transaction, as well as receipt of all required shareholder, regulatory, and other approvals. Pursuant to the terms of the Definitive Agreement, 3Win shall acquire all the shares of the Company, in the exchange ratio of ninety-eight shares of the Company per one share of 3Win. Upon completion of the Proposed Transaction, the resulting holders of all issued and outstanding shares of 3Win (“3Win Shares”) shall hold approximately 97.3% of the issued and outstanding common shares of the Resulting Issuer (the “Exchange Ratio”), subject to adjustment in certain circumstances and for any additional amounts invested by third parties into 3Win to satisfy any liquidity conditions imposed by the Exchange in connection with the Proposed Transaction. It is also anticipated that all securities convertible, exercisable or exchangeable for 3Win Shares will be converted or exchange (or otherwise become convertible or exercisable in accordance with their terms) into similar securities of the Resulting Issuer on substantially similar terms and conditions based on the Exchange Ratio. All outstanding stock options and common share purchase warrants of the Company are anticipated to remain in effect on substantially the same terms. 3WIN Corp. cancelled the acquisition of Digicann Ventures Inc. (CNSX:DCNN) in a reverse merger transaction on October 29, 2025.
お知らせ • Mar 12Digicann Ventures Inc. announced a financing transactionDigicann Ventures Inc. announced that it has entered into an agreement with the holders of the company to issue 10% Senior Unsecured Convertible Debentures to receive funding on March 12, 2025. The maturity date of the debentures is March 12, 2026.
お知らせ • Aug 043WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) for CAD 0.22 million.3WIN Corp. entered into a letter of intent to acquire Digicann Ventures Inc. (CNSX:DCNN) for CAD 0.22 million on August 1, 2024. Pursuant to the terms of the LOI, the holders of Digicann Shares shall receive a deemed value of CAD 0.05 per share and, upon completion of the Proposed Transaction3Win Corp. expects to affect a name change to “Serewin Inc.”. Completion of the Proposed Transaction is subject to a number of conditions precedent, including but not limited to, the parties entering into a Definitive Agreement, Digicann having a minimum amount of cash at closing of the Proposed Transaction, as well as receipt of all required shareholder, regulatory, and other approvals.
New Risk • May 02New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (91% average weekly change). Negative equity (-CA$620k). Shareholders have been substantially diluted in the past year (298% increase in shares outstanding). Revenue is less than US$1m. Market cap is less than US$10m (€295.1k market cap, or US$315.8k). Minor Risk Large one-off items impacting financial results.
Reported Earnings • Nov 19Third quarter 2023 earnings released: EPS: CA$0.11 (vs CA$0.87 loss in 3Q 2022)Third quarter 2023 results: EPS: CA$0.11 (up from CA$0.87 loss in 3Q 2022). Revenue: CA$113.7k (down 34% from 3Q 2022). Net income: CA$880.0k (up CA$3.25m from 3Q 2022).
お知らせ • Oct 24An unknown buyer acquired Agraflora Europe Gmbh from Digicann Ventures Inc. (CNSX:DCNN) for €0.5 million recently.An unknown buyer acquired Agraflora Europe Gmbh from Digicann Ventures Inc. (CNSX:DCNN) for €0.5 million recently on October 23, 2023. This transaction is governed exclusively by the laws of Germany subject to the exclusion of German conflicts of laws rules (IPR).
Reported Earnings • Sep 03Second quarter 2023 earnings released: EPS: CA$0.60 (vs CA$4.16 loss in 2Q 2022)Second quarter 2023 results: EPS: CA$0.60 (up from CA$4.16 loss in 2Q 2022). Revenue: CA$142.8k (up 4.1% from 2Q 2022). Net income: CA$3.64m (up CA$7.75m from 2Q 2022).